These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19479846)

  • 21. Aliphatic and aromatic oxidations, epoxidation and S-oxidation of prodrugs that yield active drug metabolites.
    Tekes K; Kalász H; Hasan MY; Adeghate E; Darvas F; Ram N; Adem A
    Curr Med Chem; 2011; 18(32):4885-900. PubMed ID: 22050741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosimulation of drug metabolism--a yeast based model.
    Pieper I; Wechler K; Katzberg M; Brusch L; Sørensen PG; Mensonides F; Bertau M
    Eur J Pharm Sci; 2009 Jan; 36(1):157-70. PubMed ID: 19041718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of Drugs and other Xenobiotics as Key Modulator of Toxicity.
    Orhan H
    Curr Drug Metab; 2021; 22(8):582-583. PubMed ID: 34636292
    [No Abstract]   [Full Text] [Related]  

  • 25. [Metabolism of drugs. II. The factors influencing metabolic reactions].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):453-6. PubMed ID: 16161933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of metabonomics at the interface between drug metabolism and safety assessment.
    Waters NJ
    Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cunninghamella--a microbial model for drug metabolism studies--a review.
    Asha S; Vidyavathi M
    Biotechnol Adv; 2009; 27(1):16-29. PubMed ID: 18775773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biochemistry of drug metabolism--an introduction: part 3. Reactions of hydrolysis and their enzymes.
    Testa B; Krämer SD
    Chem Biodivers; 2007 Sep; 4(9):2031-122. PubMed ID: 17886859
    [No Abstract]   [Full Text] [Related]  

  • 29. On the role of the peroxisome in the metabolism of drugs and xenobiotics.
    Masters CJ
    Biochem Pharmacol; 1998 Sep; 56(6):667-73. PubMed ID: 9751070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 1997 Jan; 2(7):71-5. PubMed ID: 9296908
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolites in safety testing: metabolite identification strategies in discovery and development.
    Nedderman AN
    Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiochemical drug properties associated with in vivo toxicological outcomes.
    Hughes JD; Blagg J; Price DA; Bailey S; Decrescenzo GA; Devraj RV; Ellsworth E; Fobian YM; Gibbs ME; Gilles RW; Greene N; Huang E; Krieger-Burke T; Loesel J; Wager T; Whiteley L; Zhang Y
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4872-5. PubMed ID: 18691886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear receptors: the controlling force in drug metabolism of the liver?
    Plant N; Aouabdi S
    Xenobiotica; 2009 Aug; 39(8):597-605. PubMed ID: 19622002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease, metabolism and reproduction in the toxic response to drugs and other chemicals. Proceedings of the European Society of Toxicology. Rome, March 28-30, 1983.
    Arch Toxicol Suppl; 1984; 7():1-535. PubMed ID: 6595970
    [No Abstract]   [Full Text] [Related]  

  • 35. Xenobiotic metabolism and transport in
    Hartman JH; Widmayer SJ; Bergemann CM; King DE; Morton KS; Romersi RF; Jameson LE; Leung MCK; Andersen EC; Taubert S; Meyer JN
    J Toxicol Environ Health B Crit Rev; 2021 Feb; 24(2):51-94. PubMed ID: 33616007
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolism of drugs and other xenobiotics in the gut lumen and wall.
    Ilett KF; Tee LB; Reeves PT; Minchin RF
    Pharmacol Ther; 1990; 46(1):67-93. PubMed ID: 2181492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping adverse drug reactions in chemical space.
    Scheiber J; Jenkins JL; Sukuru SC; Bender A; Mikhailov D; Milik M; Azzaoui K; Whitebread S; Hamon J; Urban L; Glick M; Davies JW
    J Med Chem; 2009 May; 52(9):3103-7. PubMed ID: 19378990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota in reductive drug metabolism.
    Guo Y; Lee H; Jeong H
    Prog Mol Biol Transl Sci; 2020; 171():61-93. PubMed ID: 32475528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
    Brandsch M
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):887-905. PubMed ID: 19519280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.
    Nicholson JK; Lindon JC; Holmes E
    Xenobiotica; 1999 Nov; 29(11):1181-9. PubMed ID: 10598751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.